The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
G | Genito urinary system and sex hormones | |
2
|
G03 | Sex hormones and modulators of the genital system | |
3
|
G03D | Progestogens | |
4
|
G03DA | Pregnen (4) derivatives |
| Code | Title | |
|---|---|---|
| G03DA01 | Gestonorone | |
| G03DA02 | Medroxyprogesterone | |
| G03DA03 | Hydroxyprogesterone | |
| G03DA04 | Progesterone |
| Active Ingredient |
|---|
|
Hydroxyprogesterone is a synthetic progestin. The mechanism by which hydroxyprogesterone reduces the risk of recurrent preterm birth is not known. Hydroxyprogesterone is indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. |
|
Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects. |
|
Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase. |
| Document | Type | Information Source | |
|---|---|---|---|
| CRINONE Vaginal gel | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CYCLOGEST Off-white pessaries | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ENDOMETRIN Vaginal insert | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| LUBION Solution for injection | MPI, EU: SmPC | ||
| LUTIGEST Vaginal tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| PROMETRIUM Capsule | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| PROVERA Tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| UTROGESTAN Capsule | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |